ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Columnist, Kushner, Four Others Names To NCAB

May 9, 1980

Rauscher To Leave ACS when It Moves To Atlanta; Gadberry To Retire In March; Other VPs Stay On

January 8, 1988

ACS Expresses Concern About “Fletcher Report” On Mammography

May 7, 1993

In Brief: Comprehensive Designation To MN Center; Bernardin Center Wins NCI Planning Grant

October 16, 1998

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009

Flow Lab Lands Top Virology Contract – $1.9 Mil.

February 21, 1975